Abstract
Solubilizing agents are routinely added when investigating the biotransformation of lipophilic substrates using hepatic microsomes. For highly lipophilic compounds, the concentration of solvent or surfactant necessary for dissolution can be detrimental to enzyme activity. This study evaluates the effect of 12 surfactants on microsomal metabolism and the ability of the same surfactants to improve the aqueous solubility of the pentabrominated diphenyl ether BDE-100, a lipophilic environmental contaminant previously found to be recalcitrant to in vitro metabolism. Of the surfactants investigated, Cremophor EL and Tween 80 displayed the best combination of increased BDE-100 solubility and minimal inhibition of microsomal metabolism. However, a comparison of the in vitro metabolism products of BDE-100 in the presence of the two surfactants revealed varying amounts of metabolites depending on the surfactant used.
Similar content being viewed by others
References
Bravo Gonzalez R. C.; Huwyler J.; Boess F.; Walter I.; Bittner B. In vitro investigation of the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharm. Drug. Dispos. 25(1): 37–49; 2004.
Busby W. F.; Ackermann J. M.; Crspi C. L. Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450. Drug. Metabol. Dispos. 27(2): 246–249; 1999.
Canton R. F.; Sanderson J. T.; Nijmeijer S.; Bergman A.; Lechter R. L.; van der Berg M. In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: a novel mechanism of action? Toxicol. Appl. Pharmacol. 216(3): 274–281; 2006.
Carlile D. J.; Stevens A. J.; Ashforth E. I.; Waghela D.; Houston J. B. In vivo clearance of ethoxycoumarin and its prediction from in vitro systems. Drug. Metab. Dispos. 26(3): 216–221; 1998.
Cheng S. W.; Randall K.; Kotchevar A. T. In vitro metabolism studies of polybrominated diphenyl ethers using rat and human microsomes. Am. J. Biochem. Biotech. 4(3): 295–303; 2008.
Christiansen A.; Backensfeld T.; Denner K.; Wietschies W. Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. Eur. J. Pharm. Biopharm. 78(1): 166–172; 2011.
Churchill P. F.; Dudley R. J.; Churchill S. A. Surfactant-enhanced bioremediation. Waste Manag. 15(5/6): 371–377; 1995.
Cotreau-Bibbo M. M.; von Moltke L. L.; Greenblatt D. J. Influence of polyethylene glycol and acetone on the in vitro biotransformation of tamoxifen and alprazolam by human liver microsomes. J. Pharm. Sci. 85(11): 1180–1185; 1996.
da Silva M. E. F.; Meirelles N. C. Interaction of non-ionic surfactants with hepatic CYP in Prochilodus scrofa. Toxicol. In Vitro 18(6): 859–867; 2004.
de Wit C. A. An overview of brominated flame retardants in the environment. Chemosphere 46(1): 83–624; 2002.
Edwards D. A.; Luthy R. G.; Liu Z. Solubilization of polycyclic aromatic hydrocarbons in micellar nonionic surfactant solutions. Environ. Sci. Technol. 25(1): 127–133; 1991.
Fendler J. H.; Fendler E. J. Catalysis in Micellar and Macromolecular Systems. Academic, New York, pp 20–21; 1975.
Grochowalski A. R.; Cooper D. G.; Nicell J. A. Effect of surfactants on plasticizer biodegradation by Bacillus subtilis ATCC 6633. Biodegradation 18(3): 283–293; 2007.
Guha S.; Jaffe P. R. Biodegradation kinetics of phenanthrene partitioned into the micellar phase of nonionic surfactants. Environ. Sci. Technol. 30(2): 605–611; 1996.
Haehner T.; Massing U.; Diesinger T.; Muller-Enoch D. Inhibition of cytochrome P450 mediated enzyme activity by alkylphosphocholines. Z. Naturforsch. 59c(7/8): 599–605; 2004.
Harju M.; Hamers T.; Kamstra J. H.; Sonneveld E.; Boon J. P.; Tysklind M.; Anderssen P. L. Quantitative structure-activity relationship modeling on in vitro endocrine effects and metabolic stability involving 26 selected brominated flame retardants. Environ. Toxicol. Chem. 26(4): 816–826; 2007.
Hickman D.; Wang J.-P.; Unadkat J. D. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. Drug. Metab. Dispos. 26(3): 207–215; 1998.
Inouye K.; Kondo S.; Yamamura M.; Nakanishi D.; Sakaki T. Inhibitory effects of detergents on rat CYP1A1-dependent mooxygenase: Comparison of mixed and fused systems consisting of rat CYP1A1 and yeast NADPH-P450 reductase. Biochem. Biophys. Res. Comm. 280(5): 1346–1351; 2001.
Iwase M.; Kurata N.; Nishimura Y.; Masamoto T.; Yasuhara H. Evaluation of the effects of hydrophilic organic solvents on CYP3A-mediated drug-drug interaction in vitro. Hum. Exp. Toxicol. 25(12): 715–721; 2006.
Lilienthal H.; Hack A.; Roth-Harer A.; Grande S. W.; Talsness C. E. Effects of developmental exposure to 2,2’4,4’5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behaviour in rats. Environ. Health Persp. 114(2): 194–201; 2006.
Lu A. Y. H.; Levin W.; Kuntzman R. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. VII. Stimulation of benzphetamine N-demethylation by lipid and detergent. Biochem. Biophys. Res. Comm. 60(1): 266–271; 1974.
Marsh G.; Hu J.; Jakobsson E.; Rahm S.; Bergman A. Synthesis and characterization of 32 polybrominated diphenyl ethers. Environ. Sci. Technol. 33(17): 3033–3037; 1999.
McKinney M. A.; De Guise S.; Martineau D.; Beland P.; Arukwe A.; Letcher R. J. Biotransformation of polybrominated diphenyl ethers and polychlorinated biphenyls in beluga whale (Delphinapterus leucas) and rat mammalian model using an in vitro hepatic microsomal assay. Aquat. Toxicol. 66(1): 87–97; 2006.
Meerts I. A. M.; van Zanden J. J.; Lujiks E. A. C.; van Leeuwen-Bol I.; Marsh G.; Jakobsson E.; Bergman A.; Brouwer A. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol. Sci. 56(1): 95–104; 2000.
Meironyte D.; Noren K.; Bergman A. Analysis of polybrominated diphenyl ethers in Swedish human milk. A time-related study, 1972–1997. J. Toxicol. Environ. Health 58(6): 329–341; 1999.
Mountfield R. J.; Senepin S.; Schleimer M.; Walter I.; Bittner B. Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. Intl. J. Pharm. 211(1): 89–92; 2000.
Mudra D. R.; Borchardt R. T. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism. J. Pharm. Sci. 99(2): 1016–1027; 2010.
Muller-Enoch D.; Fintelmann R.; Nicolaev A.; Gruler H. Enzyme activity of the cytochrome P-450 monooxygenase system in the presence of single chain lipid molecules. Z. Naturforsch. 56c(11/12): 1082–1090; 2001.
Noodman W. H.; Wacheter J. H. J.; de Boer G. J.; Janssen D. B. The enhancement of surfactants of hexadecane degradation by Pseudomonas aeruginosa varies with substrate availability. J. Biotechnol. 94(2): 195–212; 2002.
Prak D. J. L.; Pritchard P. H. Degradation of polycyclic aromatic hydrocarbons dissolved in Tween 80 surfactant solutions by Sphingomonas paucimobilis EPA 505. Can. J. Microbiol. 48(2): 151–158; 2002.
Rangel-Yagui C. O.; Pessoa Jr. A.; Tavares L. C. Micellar solubilization of drugs. J. Pharm. Pharm. Sci. 8(2): 147–163; 2005.
Ren X.; Mao X.; Cao L.; Xue K.; Si L.; Qiu J.; Schimmer A. D.; Li G. Nonionic surfactants are strong inhibitors of cytochrome P450 3A biotransformation activity in vitro and in vivo. Eur. J. Pharm. Sci. 36(4/5): 401–411; 2009.
Ren X.; Mao X.; Si L.; Cao L.; Xiong H.; Qiu J.; Schimmer A. D.; Li G. Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration. Eur. J. Pharm. Biopharm. 70(1): 279–288; 2008.
Schecter A.; Papke O.; Tung K. C.; Joseph J.; Harris T. R.; Dahlgren J. Polybrominated diphenyl ether flame retardants in the US population: Current level, temporal trends, and comparisons with dioxins, dibenzofurans, and polychlorinated biphenyls. J. Occupat. Environ. Med. 47(3): 199–211; 2005.
Sivars U.; Tjerneld F. Mechanisms of phase behaviour and protein partitioning in detergent/polymer aqueous two-phase systems for purification of integral membrane proteins. Biochim. Biophys. Acta. 1474(2): 133–146; 2000.
Turk M.; Lietzow R. Stabilized nanoparticles of physterol by rapid expansion from supercritical solution into aqueous solution. AAPS PharmSciTech 5(4): e56; 2004.
Viberg H.; Frediksson A.; Eriksson P. Neonatal exposure to polybromodiphenyl ether (PBDE-153) disrupts spontaneous behaviour, impairs learning and memory, and decreased hippocampal cholinergic receptors in adult mice. Toxicol. Appl. Pharmacol. 192(2): 95–106; 2003.
Viberg H.; Frediksson A.; Eriksson P. Deranged spontaneous behaviour and decrease in cholinergic muscarinic receptors in hippocampus in the adult rat, after neonatal exposure to the brominated flame-retardant, 2,2’4,4’,5-pentabromodiphenyl ether (PBDE99). Environ. Toxicol. Pharmacol. 20(2): 283–288; 2005.
Williamsen P. A.; Arvin E. Kinetics of degradation of surfactant-solubilized fluoranthene by a Sphingomonas paucimobilis. Environ. Sci. Technol. 35(15): 2571–2578; 1999.
Acknowledgements
We thank Mr. Jim Stanford, California State University, East Bay, Hayward, CA for his assistance with the GC–MS. This work was supported by a California State University RSCA Faculty Grant to A.T.K.
Author information
Authors and Affiliations
Corresponding author
Additional information
Editor: T. Okamoto
Rights and permissions
About this article
Cite this article
Randall, K., Cheng, S.W. & Kotchevar, A.T. Evaluation of surfactants as solubilizing agents in microsomal metabolism reactions with lipophilic substrates. In Vitro Cell.Dev.Biol.-Animal 47, 631–639 (2011). https://doi.org/10.1007/s11626-011-9449-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11626-011-9449-9